2021
DOI: 10.1016/j.clml.2020.10.004
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Hypertension and Renin-angiotensin-aldosterone System Inhibitors in Bleomycin-induced Lung Injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 52 publications
0
2
0
Order By: Relevance
“…It has been clinically proven that BLM is used mainly as a chemotherapeutic due to lack of myelosuppression and immunosuppression [1]. The glycopeptide antibiotic is administered in malignancies, testicular cancer, Hodgkin's lymphoma, but subsequently induces dose-dependent interstitial lung toxicity and lung tissue inflammation, which limits its clinical use [1,2]. BLM exerts its cytotoxic effect in vivo by cleaving the DNA structure in a biochemical process dependent on the presence of two cofactors-the molecular oxygen presence and the presence of metallic Fe (II) ion.…”
Section: Introductionmentioning
confidence: 99%
“…It has been clinically proven that BLM is used mainly as a chemotherapeutic due to lack of myelosuppression and immunosuppression [1]. The glycopeptide antibiotic is administered in malignancies, testicular cancer, Hodgkin's lymphoma, but subsequently induces dose-dependent interstitial lung toxicity and lung tissue inflammation, which limits its clinical use [1,2]. BLM exerts its cytotoxic effect in vivo by cleaving the DNA structure in a biochemical process dependent on the presence of two cofactors-the molecular oxygen presence and the presence of metallic Fe (II) ion.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the ECM remodeling effects noted above, elimination of plasma ALD secretion may provide another explanation for the protective effects of adrenalectomy in the bleomycin model. Previous research has demonstrated that RAAS antagonists are protective against bleomycin induced lung injury in patients receiving bleomycin chemotherapy [38] and angiotensin-converting enzyme inhibitors have been shown to be effective in the mitigation of fibrosis caused by the SARS-CoV-2 virus [39]. While our results are promising, further research is needed to understand the interactions between RAAS activity and pulmonary fibrosis.…”
Section: As Expected Airway Inflammation Which Has Been Associated Wi...mentioning
confidence: 69%